Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

  • Spain
  • 1

Filter Results (18)

  • LRRK2 Biology Consortium, 2017
    Kinase Activity-mediated Changes in LRRK2-Parkinson's and Sporadic Parkinson's Cells and Rab Protein Function

    Promising Outcomes of Original Grant:
    Our previous studies have demonstrated deficits in cohesion, positioning, and polarity (important characteristics of cells that help regulate function) in...

  • Research Grant, 2016
    Multi-center Study of EEG Biomarkers for Alpha-synucleinopathy Diagnosis and Prognosis Decision Support Tools Using Machine Learning

    Promising Outcomes of Original Grant:
    In our original study, the aim was to develop computational tools based on signal processing and machine learning for the diagnosis and prediction of Parkinson's...

  • Target Advancement Program, 2016
    Insights into LRRK2 Kinase Inhibitors

    Study Rationale:
    Mutations in LRRK2 cause an inherited form of Parkinson's disease (PD), and variations in LRRK2 can increase disease risk, indicating that the protein is key in the entire PD disease...

  • Target Advancement Program, 2016
    Targeting the Transcriptional Regulator of Autophagy LMX1B for Parkinson's Disease Therapeutic Development

    Study Rationale:
    LMX1B is a transcription factor that plays an essential role in the development of dopaminergic neurons. We have recently described a new role for LMX1B in dopaminergic neurons as a...

  • Rapid Response Innovation Awards, 2014
    Neuroimaging Carriers of the Alpha-synuclein E46K Mutation as a Model of Idiopathic Lewy Body Disease

    Study Rationale:
    In 2004 our group described, for the first time in literature, the E46K mutation of the alpha-synuclein gene in a family from the Basque region of Spain. The rare E46K mutation is...

  • Research Grant, 2014
    Retinal Pathology in Parkinson’s Disease: Implications for Vision and Biomarkers

    Study Rationale:                   
    Vision problems are not what most of us think of when we think of Parkinson’s disease (PD), but there are some physical changes in the retina of people with PD...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.